<DOC>
	<DOCNO>NCT00434291</DOCNO>
	<brief_summary>This study test safety efficacy TG-873870 ( Nemonoxacin ) compare Levofloxacin adult patient Community-Aquired Pneumonia ( CAP )</brief_summary>
	<brief_title>Safety Efficacy Comparison TG-873870 ( Nemonoxacin ) Levofloxacin Community-Acquired Pneumonia</brief_title>
	<detailed_description>Community-acquired Pneumonia ( CAP ) remain leading cause death develop developed country . In choice antibacterial agent use treat CAP , fluoroquinolones receive considerable attention wide spectrum bactericidal activity . TG-873870 ( Nemonoxacin ) , non-fluorinated quinolone ( NFQ ) , selective bacterial topoisomerase inhibitor . This study test safety efficacy TG-873870 ( Nemonoxacin ) compare Levofloxacin adult patient Community-Aquired Pneumonia ( CAP ) .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>If female , nonlactating risk pregnancy ( postmenopausal must use adequate birth control ) Must suitable candidate oral antibiotic therapy must able swallow capsule intact Must clinical diagnosis CAP base clinical evidence Must chest radiograph demonstrate new persistent/progressive infiltrates Must able produce sputum Clinically significant conduction abnormality 12lead ECG , QTc interval Patients CAP , investigator 's judgment , severe enough require hospitalization intravenous antibiotic therapy and/or supplemental oxygen therapy ICU support Known suspect severe bronchiectasis , cystic fibrosis , active pulmonary tuberculosis infection mycobacteria fungi , know bronchial obstruction , history postobstructive pneumonia , confound respiratory disease , lung cancer , malignancy metastatic lung , lung abscess , empyema , suspect aspiration pneumonia due vomiting , nonbacterial respiratory infection ( chronic obstructive pulmonary disease [ COPD ] exclusionary ) Infection acquire hospital , nursing home , longterm care facility , hospitalization reason within previous 14 day Treatment antibiotic within past 7 day prior randomization , unless document treatment failure ( 72 hour treatment respond ) Anticipation requirement additional treatment nonstudy antibacterial reason patient 's participation study Treatment chemotherapeutic agent oncolytics 6 month prior randomization anticipate requirement agent course study Known suspect CNS disorder may predispose patient seizure low seizure threshold</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Community-acquired Pneumonia</keyword>
	<keyword>fluoroquinolone</keyword>
	<keyword>TG-873870</keyword>
	<keyword>Nemonoxacin</keyword>
</DOC>